Savara (SVRA) Stock: Buy, Sell, or Hold?
$4.72
-0.27 (-5.41%)
▼
5d:
+7.76%
30d:
-0.84%
90d:
-12.27%
QUANTITATIVE VERDICT
HOLD
LOW Confidence (45%)
Quality Score
57/100
Position
FAIR
30-Day Fair Range
$4.56 – $4.93
Position: FAIR
Forward P/E & Valuation
-13.4x
Next 12M consensus est.
Wall Street Target
$11.06
+134.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$4.33 / $5.21
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: SVRA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When SVRA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: SVRA is currently trading at $4.72, which is considered fair relative to its 30-day fair value range of $4.56 to $4.93.
Technical Outlook: Technically, SVRA is in a strong downtrend. Immediate support is located at $4.33, while resistance sits at $5.21. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: SVRA scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.06 (+134.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, SVRA is in a strong downtrend. Immediate support is located at $4.33, while resistance sits at $5.21. Short-term momentum is weak, with the stock down 5.4% recently.
Market Sentiment: SVRA scores 36/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $11.06 (+134.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.56 -
$4.93
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
Trading Range & Key Levels
30-Day Trading Range
$4.56 -
$4.93
Current vs Trading Range
FAIR
Support Level
$4.33
Resistance Level
$5.21
Current Trend
Strong Downtrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (36/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.4%)
- BULLISH: Trading 134.2% below Wall St target ($11.06)
Fundamental Context
Forward P/E (Next Year Est.)
-13.39
Wall Street Target
$11.06
(+134.2%)
Share SVRA Analysis
Share this live SVRA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (SVRA)
Bullish
2 Retail Mentions
Reddit / WSB Comments
1
Bearish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Traders on StockTwits express bullish sentiment towards $SVRA, anticipating potential acquisition interest ahead of FDA decision for Molbreevi on November 22, 2026.
Key Retail Themes:
Acquisition speculation
FDA decision for Molbreevi
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 13, 2026 6:13 AM ET
Data refreshes hourly during market hours. Next update: 7:13 AM
Data refreshes hourly during market hours. Next update: 7:13 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SVRA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
24 analysts |
$145 | 37 SELL |
|
ARGX
argenx NV ADR |
STRONG BUY
23 analysts |
$1147 | 31 SELL |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
18 analysts |
$139 | 41 HOLD |
|
IRD
Opus Genetics, Inc. |
STRONG BUY
18 analysts |
$13 | 39 SELL |
|
SYRE
Spyre Therapeutics Inc. |
STRONG BUY
18 analysts |
$122 | 44 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive SVRA Research Pages